Position in TGTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$34,205,808
+$29,406,482 QoQ
Shares Held
622,603
+331.0% QoQ
Ownership
0.407%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#31
of 426 holders
Holding Since
Sep 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HRT FINANCIAL LP holds $857,639,414 across 185 Biotechnology names. TGTX ranks #8 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
1,089,376 | $81,136,724 | |
| 2 | INSM |
INSMED Inc
|
689,981 | $73,565,774 | |
| 3 | EXEL |
Exelixis, Inc.
|
929,242 | $50,560,057 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
84,634 | $45,444,226 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
178,491 | $43,689,242 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
498,655 | $40,645,369 | |
| 7 | ABVX |
Abivax S.A.
|
270,612 | $36,061,755 | |
| 8 | TGTX |
Tg Therapeutics, Inc.
This page
|
622,603 | $34,205,808 |
All Filings in TGTX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $34,205,808 | 622,603 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $4,799,326 | 144,471 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $5,823,651 | 195,359 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $3,911,651 | 108,281 | Shares | Defined | 2025-11-14 | |
| 2023-12-31 | $1,307,354 | 76,543 | Shares | Defined | 2024-02-09 | |
| 2023-06-30 | $518,361 | 20,868 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,142,036 | 208,912 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,910,071 | 161,460 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $508,983 | 85,977 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||